Barbara Jaworska

Barbara Jaworska

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
GRGabriela Różańska-Smuszkiewicz
Gabriela Różańska-Smuszkiewicz
PSPaweł Smuszkiewicz-Różański
Paweł Smuszkiewicz-Różański
WKWeronika Kmiotek
Weronika Kmiotek
DRDagmara Ragan
Dagmara Ragan
RORadosław Oronowicz
Radosław Oronowicz
GJGrzegorz Jama
Grzegorz Jama
Polycystic ovary syndrome (PCOS) is an endocrine disorder caused by multiple genetic and environmental factors, affecting women of reproductive age but extending across all stages of a woman's life [1]. Major symptoms in many PCOS patients include menstrual cycle irregularities, difficulties in maintaining normal body weight, excessive body hair growth, acne, and fertility problems. The prevalence of PCOS varies depending on the definition used, ranging between 6-20%, making it the most common endocrine disorder among women of reproductive age [2,3]. It accounts for approximately 80% of cases of anovulatory infertility, disrupting various stages of the reproductive axis. Evidence from numerous studies suggests that lifestyle modification should be the first-line therapy for women with PCOS [4]. This paper focuses on research evaluating the treatment of this condition through lifestyle changes, physical activity, and diet. Such therapeutic interventions can significantly improve clinical outcomes and the health profile of PCOS patients by promoting favorable changes in body composition, partially normalizing sex hormone levels, reducing inflammatory parameters, and improving mental health. Therefore, the adoption of comprehensive lifestyle modifications is crucial in the treatment of polycystic ovary syndrome.

18 May 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
APAldona Pażyra
Aldona Pażyra
PSPaweł Stanicki
Paweł Stanicki
JSJulita Szarpak
Julita Szarpak
NKNatalia Kusak
Natalia Kusak
NŻNatalia Żak
Natalia Żak
BJBarbara Jaworska
Barbara Jaworska
In 2019, according to WHO estimates, 262 million people were affected by asta, resulting in 455,000 deaths. Asthma, is a chronic inflammatory disease of the airways that causes reversible bronchoconstriction, making it difficult for patients to breathe. Exacerbations of the disease can be caused by a variety of factors but share similar symptoms such as wheezing, coughing, shortness of breath and chest tightness. Severe asthma exacerbations are defined as symptoms that do not respond to inhaled medications and improve only after oral or intravenous steroid administration. Asthma-related deaths often occur during exacerbations. Vitamin D, which is produced naturally in the body and found in some foods, is a steroid-derived vitamin. Adequate doses of this vitamin, administered through medication or supplements, can be used to maintain its proper levels in the organism. Vitamin D is essential for regulating calcium levels in the body and for bone remodeling. It also has immunomodulatory effects, affecting both innate and adaptive immunity. This partly explains its association with changes in the airway epithelium that occur as a result of inflammation in asthma. The study aims to summarize the current knowledge on the relationship of vitamin D with asthma symptom control. The present study is based on literature available in scientific databases from 2013-2016, such as PubMed, Corchane Library and Google Scholar, using the following keywords: "vitamin D" and "asthma." Vitamin D deficiency is prevalent in children and adults worldwide. A critical analysis of the literature reveals that the therapeutic administration of vitamin D has no apparent advantage in treating asthma, especially in children. Nevertheless, for adults with mild asthma, vitamin D supplementation shows promise for improved outcomes. However, there is a pressing need for large-scale clinical trials to determine the efficacy and safety of this therapeutic approach for both age groups.

21 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PSPaweł Stanicki
Paweł Stanicki
JSJulita Szarpak
Julita Szarpak
APAldona Pażyra
Aldona Pażyra
NKNatalia Kusak
Natalia Kusak
NŻNatalia Żak
Natalia Żak
BJBarbara Jaworska
Barbara Jaworska
INTRODUCTION AND PURPOSE: Long non-coding RNAs are key regulators of gene expression and tumorigenesis. Deleted in leukemia 1 (DLEU1) is significant in cancer development. This article reviews DLEU1's role across cancers, assessing its diagnostic and therapeutic potential. METHODS: A review of scientific articles from PubMed and Google Scholar was conducted. DESCRIPTION OF THE STATE OF KNOWLEDGE: DLEU1 drives tumor growth in glioblastoma, esophageal, colorectal, and oral cancers by interacting with key miRNAs and genes, promoting malignancy. In breast and ovarian cancers, DLEU1 modulates migration and invasion via specific pathways. In cervical cancer, DLEU1 is linked to immune modulation and serves as a prognostic marker. SUMMARY: DLEU1 is a vital regulator in various cancers, offering potential as a diagnostic and therapeutic target.

18 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
RORadoslaw Oronowicz
Radoslaw Oronowicz
WKWeronika Kmiotek
Weronika Kmiotek
GRGabriela Różańska-Smuszkiewicz
Gabriela Różańska-Smuszkiewicz
PSPaweł Smuszkiewicz-Różański
Paweł Smuszkiewicz-Różański
AKAleksandra Karuś
Aleksandra Karuś
JDJoanna Długosz
Joanna Długosz
Introduction and Purpose: More and more alternatives to traditional smoking are available on shop shelves. Are other ways of using nicotine healthier for us? What are the advantages and disadvantages? The aim of this article is to trace the health effects of new, popular alternatives to the traditional cigarette. Materials and methods: A literature search was conducted using the medical databases PubMed and Google Scholar. Articles were retrieved in English, employing the key words: “Iqos”, “Glo”, „ e-cigarette” and „ tobacco” appropriate configurations. Conclusions: Modern tobacco devices, such as IQOS and Glo, emit significantly less harmful substances than traditional cigarettes. In particular, emissions of carbon monoxide, formaldehyde and polycyclic aromatic hydrocarbons are significantly lower. Nevertheless, nicotine remains the main ingredient in these products, with serious health risks. Regular use of nicotine can lead to addiction, cardiovascular disease and problems with the nervous system and oral cavity. Inhaling aerosol from tobacco devices such as IQOS, Glo and disposable e-cigarettes can lead to damage to lung cells and other respiratory health problems. Despite the lower risks, the use of alternative smoking methods is still harmful to our health.

20 September 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NŻNatalia Żak
Natalia Żak
ABAleksandra Błaszczyk
Aleksandra Błaszczyk
APAldona Pażyra
Aldona Pażyra
NKNatalia Kusak
Natalia Kusak
BJBarbara Jaworska
Barbara Jaworska
PSPaweł Stanicki
Paweł Stanicki
Background: In 2020, the World Health Organization (WHO) estimated that 650 million adults worldwide are obese, and 2.8 billion individuals struggle with overweight. Obesity is associated with an increased risk of cardiovascular diseases, type 2 diabetes, heart disease, adverse effects on mental health, the development of certain cancers, and other conditions. In recent years, there has been growing interest in the role of melatonin, which has therapeutic potential in the treatment of obesity. Studies suggest that melatonin supplementation may lead to weight reduction and improvement in metabolic parameters, significantly reduce cardiovascular disease risk factors, and enhance insulin sensitivity in obese individuals. Aim of study: This review aims to present the latest scientific findings on the impact of melatonin supplementation on the development of obesity and its complications. We focus primarily on the mechanisms of melatonin's action in the context of obesity, particularly on potential pathways that have not yet been thoroughly explored. Our aim is to provide deeper insights into research on obesity and its prevention. Materials and Methods: Search was conducted using PubMed and Google Scholar databases, utilizing the keywords "obesity," "melatonin," and "weight loss" in various configurations. The review primarily considers studies published after 2016 that are available online. Summary Melatonin supplementation leads to a statistically significant reduction in blood glucose levels and an increase in cellular insulin sensitivity. Its promising properties in the treatment of obesity have been demonstrated through the reduction of oxidative stress, indicating a potential adjunct for weight loss. Based on the cited studies, the beneficial effects of melatonin supplementation on cardiovascular risk factors have been confirmed. Melatonin could be considered as an adjunctive therapy for obese individuals who do not respond to other treatment modalities.

9 January 2024 in OncoReview
Verified
Journal Article
Open access
PDF file
APAldona Pażyra
Aldona Pażyra
NKNatalia Kusak
Natalia Kusak
NŻNatalia Żak
Natalia Żak
BJBarbara Jaworska
Barbara Jaworska
We report a rare case of intraocular metastasis of small cell lung cancer with disease progression.